UCB S.A. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
UCB S.A. (UCB or ‘the company’) is a global biopharmaceutical company. It focuses on the discovery and development of medicines for people living with severe diseases in two therapeutic areas, immunology and neurology. UCB also offers a range of products for the treatment of patients with epilepsy, Parkinson’s disease, restless legs syndrome, axial spondyloarthritis, Crohn's disease, psoriatic arthritis, rheumotoid arthritis, Osteoporo, Lupus, and Psoriasis, among others. The company’s major brands include Cimzia, Vimpat, Keppra, Briviact, Neupro, Nayzilam, Evenity, Cirrus, Zyrtec, and Xyzal. The company operates across Europe, North America, and Asia-Pacific. The company is headquartered in Brussels, Belgium.Scope
- Detailed information on UCB S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting UCB S.A. in the form of a SWOT analysis
- An in-depth view of the business model of UCB S.A. including a breakdown and examination of key business segments
- Intelligence on UCB S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about UCB S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of UCB S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess UCB S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on UCB S.A.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- UCB S.A.: Company Overview
- UCB S.A.: Overview and Key Facts
- UCB S.A.: Overview
- UCB S.A.: Key Facts
- UCB S.A.: Key Employees
- UCB S.A.: Key Employee Biographies
- UCB S.A.: Major Products and Services
- UCB S.A.: Management Statement
- UCB S.A.: Locations and Subsidiaries
- UCB S.A.: Key Competitors
- UCB S.A.: Company Analysis
- UCB S.A.: Business Description
- UCB S.A.: SWOT Analysis
- UCB S.A.: SWOT Overview
- UCB S.A.: Strengths
- UCB S.A.: Weaknesses
- UCB S.A.: Opportunities
- UCB S.A.: Threats
- UCB S.A.: Corporate Financial Deals Activity
- UCB S.A.: Financial Deals Overview
- UCB S.A.: Targets and Partners
- UCB S.A.: Top Deals 2020 - 2024YTD*
- UCB S.A.: Advisors
- UCB S.A.: Top Legal Advisors
- UCB S.A.: Top Financial Advisors
- UCB S.A.: Mergers and Acquisitions
- UCB S.A.: Corporate Venturing
- UCB S.A.: Capital Raising
- UCB S.A.: Partnership
- UCB S.A.: Divestments
- UCB S.A.: Recent Developments
- UCB S.A.: News and Events Summary
- UCB S.A.: Contracts
- UCB S.A.: Corporate Governance
- UCB S.A.: Financial Deals
- UCB S.A.: Financial Performance
- UCB S.A.: Market Developments
- UCB S.A.: Research & Development
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: UCB S.A.: Key Facts
- Table 2: UCB S.A.: Key Employees
- Table 3: UCB S.A.: Locations and Subsidiaries
- Table 4: UCB S.A.: Key Competitors
- Table 5: UCB S.A.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: UCB S.A.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 7: UCB S.A.: M&A Average Deal Size - Value (US$m)
- Table 8: UCB S.A.: Targets and Partners
- Table 9: UCB S.A.: Top Deals 2020 - 2024YTD*
- Table 10: UCB S.A.: Legal Advisor Ranking by Value (US$m)
- Table 11: UCB S.A.: Financial Advisor Ranking by Value (US$m)
- Table 12: UCB S.A.: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 13: UCB S.A.: M&A Activity by Geography (2020 - YTD*2024)
- Table 14: UCB S.A.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Table 15: UCB S.A.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 16: UCB S.A.: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 17: UCB S.A.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 18: UCB S.A.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 19: UCB S.A.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Table 20: UCB S.A.: News and Events Summary
- Table 21: UCB S.A.: Contracts
- Table 22: UCB S.A.: Corporate Governance
- Table 23: UCB S.A.: Financial Deals
- Table 24: UCB S.A.: Financial Performance
- Table 25: UCB S.A.: Market Developments
- Table 26: UCB S.A.: Research & Development
- Figure 1: UCB S.A.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: UCB S.A.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 3: UCB S.A.: M&A Average Deal Size - Value (US$m)
- Figure 4: UCB S.A.: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 5: UCB S.A.: M&A Activity by Geography (2020 - YTD*2024)
- Figure 6: UCB S.A.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Figure 7: UCB S.A.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 8: UCB S.A.: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 9: UCB S.A.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 10: UCB S.A.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Figure 11: UCB S.A.: Divestments Volume and Value Trend (2020 - YTD*2024)
